Axon Enterprise, Inc (NASDAQ:AXON) Stock Has Consensus Target Price of $688.38 According to Brokerages

Axon Enterprise, Inc (NASDAQ:AXON) has earned an average rating of “Moderate Buy” from the seventeen research firms that are presently covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $612.18.

A number of brokerages recently issued reports on AXON. The Goldman Sachs Group lowered their price target on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a report on Monday, September 21st. TD Cowen lowered their target price on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating on the stock in a research report on Monday, October 26th. Piper Sandler reissued an “overweight” rating and set a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. Argus upped their price target on Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, September 3rd. Finally, Morgan Stanley lifted their price objective on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th.

Insider Activity

In other news, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares of the company’s stock, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 37,397 shares of company stock worth $21,234,034. Company insiders own 4.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of AXON. Keating Financial Advisory Services Inc. acquired a new stake in Axon Enterprise during the second quarter worth about $31,000. Washington Trust Advisors Inc. lifted its stake in shares of Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after purchasing an additional 65 shares in the last quarter. Morse Asset Management Inc acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at about $30,000. M & L Capital Management Ltd acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at about $30,000. Finally, Wealth Enhancement Trust Services Inc. purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $33,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON stock opened at $302.54 on Friday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The firm’s 50-day moving average is $430.30 and its two-hundred day moving average is $472.14. Axon Enterprise has a 12 month low of $291.45 and a 12 month high of $665.07. The company has a market capitalization of $24.64 billion, a PE ratio of 96.97, a price-to-earnings-growth ratio of 5.76 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The firm’s revenue for the quarter was up 27.8% on a year-over-year basis. During the same quarter last year, the company earned $1.17 earnings per share. Analysts predict that Axon Enterprise will post 2.10 earnings per share for the current year.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will become its U.S. public-safety distributor. The deal could broaden Axon’s public-safety technology offering, though its scale also brings investment and execution risks. Axon invests in Skydio
• Positive Sentiment: West Fargo police plan to replace Flock technology with Axon’s system, including new AI features—an example of continued adoption by public-safety customers. West Fargo police adoption
• Positive Sentiment: Despite lowering its price target, Barclays retained an “overweight” rating at $507; Northland reportedly still sees a $540 target after the stock’s steep fall from its August high. These views suggest some analysts see substantial recovery potential, though targets are not guarantees. Northland target outlook
• Neutral Sentiment: A short-interest report lists 0 shares short, despite describing a large increase. The figure appears inconsistent and does not provide a reliable indication of short-selling pressure.
• Negative Sentiment: Axon’s third-quarter adjusted EPS of $1.72 and revenue of about $909 million fell short of estimates. Cautious guidance and roughly $130 million in federal-contract revenue shifting out of 2026 have weighed on the outlook; shares have fallen sharply since the results, while Motorola rose after its earnings beat. Axon versus Motorola after earnings
• Negative Sentiment: Law firms announced investigations into potential securities-law violations. These are allegations under investigation, not findings of wrongdoing, but may add legal and reputational uncertainty for investors. Axon securities investigation notice

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.